Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell A Jackson

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Cataract and Refractive Surgery|October 4, 2015
August consultation #5Mitchell A Jackson
Clinical Ophthalmology (Auckland, N.Z.)|February 29, 2020
Optimum Refractive Target in Patients with Bilateral Implantation of Extended Depth of Focus Intraocular LensesMitchell A Jackson, Anna M Edmiston, Raman Bedi
Journal of Cataract and Refractive Surgery|June 13, 2017
Intracameral ketorolac and phenylephrine effect on intraoperative pupil diameter and postoperative pain in cataract surgeryEric D Donnenfeld, J Steven Whitaker, Mitchell A Jackson, et al.
Clinical Ophthalmology (Auckland, N.Z.)|October 4, 2011
Efficacy of a new prescription-only medical food supplement in alleviating signs and symptoms of dry eye, with or without concomitant cyclosporine AMitchell A Jackson, Kim Burrell, Ian B Gaddie, et al.
Clinical Ophthalmology (Auckland, N.Z.)|May 31, 2014
The efficacy of bromfenac ophthalmic solution 0.07% dosed once daily in achieving zero-to-trace anterior chamber cell severity following cataract surgerySteven M Silverstein, Mitchell A Jackson, Damien F Goldberg, et al.
Clinical Ophthalmology (Auckland, N.Z.)|November 27, 2015
A retrospective analysis of the postoperative use of loteprednol etabonate gel 0.5% following laser-assisted in situ keratomileusis or photorefractive keratectomy surgeryClifford L Salinger, Michael Gordon, Mitchell A Jackson, et al.
Eye and Vision (London, England)|August 17, 2017
Visual outcomes 24 months after LaserACEAnnMarie Hipsley, David Hui-Kang Ma, Chi-Chin Sun, et al.
Cornea|September 28, 2021
TearCare for the Treatment of Meibomian Gland Dysfunction in Adult Patients With Dry Eye Disease: A Masked Randomized Controlled TrialPreeya K Gupta, Edward J Holland, John Hovanesian, et al.
Ophthalmology and Therapy|March 2, 2022
In Vitro and In-Eye Comparison of Commercial Pilocarpine Ophthalmic Solution and an Optimized, Reformulated Pilocarpine for Presbyopia TreatmentMitchell A Jackson, Jaya Giyanani, Yumna Shabaik, et al.
JAMA Ophthalmology|October 7, 2021
Efficacy of Lifitegrast Ophthalmic Solution, 5.0%, in Patients With Moderate to Severe Dry Eye Disease: A Post Hoc Analysis of 2 Randomized Clinical TrialsEdward J Holland, Mitchell A Jackson, Eric Donnenfeld, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Cataract and Refractive Surgery|October 4, 2015
August consultation #5Mitchell A Jackson
Clinical Ophthalmology (Auckland, N.Z.)|February 29, 2020
Optimum Refractive Target in Patients with Bilateral Implantation of Extended Depth of Focus Intraocular LensesMitchell A Jackson, Anna M Edmiston, Raman Bedi
Journal of Cataract and Refractive Surgery|June 13, 2017
Intracameral ketorolac and phenylephrine effect on intraoperative pupil diameter and postoperative pain in cataract surgeryEric D Donnenfeld, J Steven Whitaker, Mitchell A Jackson, et al.
Clinical Ophthalmology (Auckland, N.Z.)|October 4, 2011
Efficacy of a new prescription-only medical food supplement in alleviating signs and symptoms of dry eye, with or without concomitant cyclosporine AMitchell A Jackson, Kim Burrell, Ian B Gaddie, et al.
Clinical Ophthalmology (Auckland, N.Z.)|May 31, 2014
The efficacy of bromfenac ophthalmic solution 0.07% dosed once daily in achieving zero-to-trace anterior chamber cell severity following cataract surgerySteven M Silverstein, Mitchell A Jackson, Damien F Goldberg, et al.
Clinical Ophthalmology (Auckland, N.Z.)|November 27, 2015
A retrospective analysis of the postoperative use of loteprednol etabonate gel 0.5% following laser-assisted in situ keratomileusis or photorefractive keratectomy surgeryClifford L Salinger, Michael Gordon, Mitchell A Jackson, et al.
Eye and Vision (London, England)|August 17, 2017
Visual outcomes 24 months after LaserACEAnnMarie Hipsley, David Hui-Kang Ma, Chi-Chin Sun, et al.
Cornea|September 28, 2021
TearCare for the Treatment of Meibomian Gland Dysfunction in Adult Patients With Dry Eye Disease: A Masked Randomized Controlled TrialPreeya K Gupta, Edward J Holland, John Hovanesian, et al.
Ophthalmology and Therapy|March 2, 2022
In Vitro and In-Eye Comparison of Commercial Pilocarpine Ophthalmic Solution and an Optimized, Reformulated Pilocarpine for Presbyopia TreatmentMitchell A Jackson, Jaya Giyanani, Yumna Shabaik, et al.
JAMA Ophthalmology|October 7, 2021
Efficacy of Lifitegrast Ophthalmic Solution, 5.0%, in Patients With Moderate to Severe Dry Eye Disease: A Post Hoc Analysis of 2 Randomized Clinical TrialsEdward J Holland, Mitchell A Jackson, Eric Donnenfeld, et al.
Pageof 2